Bellus Health Inc (BLUSF) 0.1920 $BLUSF Researc
Post# of 273319
Posted On: 09/24/2016 3:16:56 AM
Bellus Health Inc (BLUSF) 0.1920 $BLUSF
Research Reports Initiated on Healthcare Stocks GeneNews, BELLUS Health, Helius Medical Technologies, and Centric Health
ACCESSWIRE - Tue Aug 16, 8:15AM CDT
LONDON, UK / ACCESSWIRE / August 16, 2016 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Healthcare sector. Companies recently under review include GeneNews, BELLUS Health, Helius Medical Technologies, and Centric Health. Get all of our free research reports by signing up at: http://www.activewallst.com/register/.
CHH.TO: 0.39 (unch), BLU.TO: 0.26 (unch), HSM.TO: 1.41 (-0.03), GEN.TO: 0.39 (-0.05)
Victoria Square Ventures Inc. - Note held by Victoria Square Ventures Inc. converted into common shares of BELLUS Health Inc.
CNW Group - Fri Jan 01, 9:31AM CST
Victoria Square Ventures Inc. ("VSVI"
, a wholly owned subsidiary of Power Corporation of Canada, issues this press release pursuant to applicable requirements of Canadian securities legislation. VSVI announces that the $10,930,243 non-interest bearing note (the "Note" of BELLUS Health Inc. (the "Company" held by VSVI, has been converted at its maturity today, pursuant to its terms, into 7,286,828 common shares of the Company ("Common Shares" .
BELLUS Health Inc. - "The Perils Of A Big Pharma Partnership"
ACCESSWIRE - Tue Dec 01, 9:10AM CST
NEW YORK, NY / ACCESSWIRE / December 1, 2015 / BELLUS Health Inc. (TSX: BLU) (OTC: BLUSF) today published a new blog post on The Chairman's Blog, written by the Company's President and Chief Executive Officer, Roberto Bellini. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
AGN: 243.94 (+0.51), BLU.TO: 0.26 (unch)
Three Canadian Biotechs with Pending Catalysts
ACCESSWIRE - Wed Oct 14, 11:02AM CDT
CORAL GABLES, FL / ACCESSWIRE / October 14, 2015 / In the rush of sector-wide biotech news, especially since Hillary Clinton's now infamous tweet that rocked the entire sector late last month, some developments that would have otherwise been big news may have gotten a bit lost in the ruckus. This is even more the case with foreign stocks that already receive less focus than US-based biotechs. Lest we lose sight of potential opportunities, here are three Canadian biotechs with catalysts pending.
HZNP: 19.43 (+0.02), TRIL: 15.99 (+1.33)
Bellus Health Inc. - "Temperature Running Hot at The World Orphan Drug Conference"
ACCESSWIRE - Mon Jun 15, 8:10AM CDT
NEW YORK, NY / ACCESSWIRE / June 15, 2015 / BELLUS Health Inc. (TSX: BLU) today published a new blog post on The Chairman's Blog, written by the Company's President and Chief Executive Officer, Roberto Bellini. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
BLU.TO: 0.26 (unch)
Bellus Health Inc. - "Drugs are Big Business and Business is Booming in the Orphan Drug Space"
ACCESSWIRE - Mon Jun 01, 7:05AM CDT
NEW YORK, NY / ACCESSWIRE / June 1, 2015 / BELLUS Health Inc. (TSX: BLU) today published a new blog post on The Chairman's Blog, written by the Company's Vice President, Business Development, Tony Matzouranis. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
BLU.TO: 0.26 (unch)
BELLUS Health Inc - "Our Big Shift Into Rare Diseases"
ACCESSWIRE - Tue Apr 21, 10:06AM CDT
NEW YORK, NY / ACCESSWIRE / April 21, 2015 / BELLUS Health Inc. (TSX: BLU) today published a new blog post on The Chairman's Blog, written by the Company's President and Chief Executive Officer, Roberto Bellini. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
BLU.TO: 0.26 (unch)
BELLUS Health Inc. - "We Have a Plan"
ACCESSWIRE - Tue Mar 17, 9:46AM CDT
NEW YORK, NY / ACCESSWIRE / March 17, 2015 / BELLUS Health Inc. (TSX: BLU) today published a new blog post on The Chairman's Blog, written by the Company's President and Chief Executive Officer, Roberto Bellini. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
BLU.TO: 0.26 (unch)
Research Reports Initiated on Healthcare Stocks GeneNews, BELLUS Health, Helius Medical Technologies, and Centric Health
ACCESSWIRE - Tue Aug 16, 8:15AM CDT
LONDON, UK / ACCESSWIRE / August 16, 2016 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Healthcare sector. Companies recently under review include GeneNews, BELLUS Health, Helius Medical Technologies, and Centric Health. Get all of our free research reports by signing up at: http://www.activewallst.com/register/.
CHH.TO: 0.39 (unch), BLU.TO: 0.26 (unch), HSM.TO: 1.41 (-0.03), GEN.TO: 0.39 (-0.05)
Victoria Square Ventures Inc. - Note held by Victoria Square Ventures Inc. converted into common shares of BELLUS Health Inc.
CNW Group - Fri Jan 01, 9:31AM CST
Victoria Square Ventures Inc. ("VSVI"
, a wholly owned subsidiary of Power Corporation of Canada, issues this press release pursuant to applicable requirements of Canadian securities legislation. VSVI announces that the $10,930,243 non-interest bearing note (the "Note" of BELLUS Health Inc. (the "Company" held by VSVI, has been converted at its maturity today, pursuant to its terms, into 7,286,828 common shares of the Company ("Common Shares" . BELLUS Health Inc. - "The Perils Of A Big Pharma Partnership"
ACCESSWIRE - Tue Dec 01, 9:10AM CST
NEW YORK, NY / ACCESSWIRE / December 1, 2015 / BELLUS Health Inc. (TSX: BLU) (OTC: BLUSF) today published a new blog post on The Chairman's Blog, written by the Company's President and Chief Executive Officer, Roberto Bellini. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
AGN: 243.94 (+0.51), BLU.TO: 0.26 (unch)
Three Canadian Biotechs with Pending Catalysts
ACCESSWIRE - Wed Oct 14, 11:02AM CDT
CORAL GABLES, FL / ACCESSWIRE / October 14, 2015 / In the rush of sector-wide biotech news, especially since Hillary Clinton's now infamous tweet that rocked the entire sector late last month, some developments that would have otherwise been big news may have gotten a bit lost in the ruckus. This is even more the case with foreign stocks that already receive less focus than US-based biotechs. Lest we lose sight of potential opportunities, here are three Canadian biotechs with catalysts pending.
HZNP: 19.43 (+0.02), TRIL: 15.99 (+1.33)
Bellus Health Inc. - "Temperature Running Hot at The World Orphan Drug Conference"
ACCESSWIRE - Mon Jun 15, 8:10AM CDT
NEW YORK, NY / ACCESSWIRE / June 15, 2015 / BELLUS Health Inc. (TSX: BLU) today published a new blog post on The Chairman's Blog, written by the Company's President and Chief Executive Officer, Roberto Bellini. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
BLU.TO: 0.26 (unch)
Bellus Health Inc. - "Drugs are Big Business and Business is Booming in the Orphan Drug Space"
ACCESSWIRE - Mon Jun 01, 7:05AM CDT
NEW YORK, NY / ACCESSWIRE / June 1, 2015 / BELLUS Health Inc. (TSX: BLU) today published a new blog post on The Chairman's Blog, written by the Company's Vice President, Business Development, Tony Matzouranis. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
BLU.TO: 0.26 (unch)
BELLUS Health Inc - "Our Big Shift Into Rare Diseases"
ACCESSWIRE - Tue Apr 21, 10:06AM CDT
NEW YORK, NY / ACCESSWIRE / April 21, 2015 / BELLUS Health Inc. (TSX: BLU) today published a new blog post on The Chairman's Blog, written by the Company's President and Chief Executive Officer, Roberto Bellini. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
BLU.TO: 0.26 (unch)
BELLUS Health Inc. - "We Have a Plan"
ACCESSWIRE - Tue Mar 17, 9:46AM CDT
NEW YORK, NY / ACCESSWIRE / March 17, 2015 / BELLUS Health Inc. (TSX: BLU) today published a new blog post on The Chairman's Blog, written by the Company's President and Chief Executive Officer, Roberto Bellini. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
BLU.TO: 0.26 (unch)
(0)
(0)